Search Results - "Loli, Paola"
-
1
COVID-19 and the pituitary
Published in Pituitary (01-06-2021)“…Background Despite COVID-19 being identified as severe respiratory viral infection, progressively many relevant endocrine manifestations have been reported…”
Get full text
Journal Article -
2
Transition from Hashimoto thyroiditis to Graves’s Disease: an unpredictable change?
Published in Endocrine (01-05-2024)“…Purpose Hashimoto thyroiditis and Graves’s disease are two related autoimmune disorders, representing the leading causes of hypothyroidism and hyperthyroidism…”
Get full text
Journal Article -
3
COVID-19 and hypopituitarism
Published in Reviews in endocrine & metabolic disorders (01-04-2022)“…Besides the pulmonary manifestations caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), an emerging endocrine phenotype, which can…”
Get full text
Journal Article -
4
Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour?
Published in Endocrine (01-03-2022)“…Purpose Adrenal schwannomas (AS) are rare tumours arising from Schwann cells. Due to the high prevalence of adrenal incidentalomas, running into very rare…”
Get full text
Journal Article -
5
Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
Published in Endocrine (01-03-2021)“…Adrenal insufficiency (AI) is a life-threatening condition requiring life-long glucocorticoid (GC) substitution therapy, as well as stress adaptation to…”
Get full text
Journal Article -
6
Bilateral inferior petrosal sinus sampling
Published in Endocrine Connections (01-07-2016)“…Simultaneous bilateral inferior petrosal sinus sampling (BIPSS) plays a crucial role in the diagnostic work-up of Cushing’s syndrome. It is the most accurate…”
Get full text
Journal Article -
7
Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors
Published in European journal of endocrinology (01-12-2006)“…Objective: The long-term outcome of non-functioning pituitary adenoma (NFPA) patients is not clearly established, probably due to the low annual incidence and…”
Get full text
Journal Article -
8
Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study
Published in Clinical endocrinology (Oxford) (01-12-2009)“…Summary Objective The long‐term efficacy and safety of stereotactic radiosurgery by gamma knife (GK) still remain unknown. The aim of the study was to…”
Get full text
Journal Article -
9
La supplementazione steroidea perioperatoria nel paziente iposurrenalico
Published in L'Endocrinologo (2022)Get full text
Journal Article -
10
Gamma-Knife Radiosurgery in Acromegaly: A 4-Year Follow-Up Study
Published in The journal of clinical endocrinology and metabolism (01-07-2003)“…Stereotactic radiosurgery by gamma-knife (GK) is an attractive therapeutic option after failure of microsurgical removal in patients with pituitary adenoma. In…”
Get full text
Journal Article -
11
Acute coronary syndrome: a rare case of multiple endocrine neoplasia syndromes with pheochromocytoma and medullary thyroid carcinoma
Published in Cancer biology & medicine (01-09-2015)“…Pheochromocytoma is a tumor arising from neuroectodermal chromaffin tissues in the adrenal gland or extra-adrenal paraganglia (paragangliomas). The prevalence…”
Get full text
Journal Article -
12
High expression of dopamine receptor subtype 2 in a large series of neuroendocrine tumors
Published in Cancer biology & therapy (01-12-2008)“…Background/Aims: Recent data in vitro and in vivo support that dopaminergic drugs might exert an inhibitory effect on hormone secretion and, possibly, on tumor…”
Get full text
Journal Article -
13
Correction: Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how
Published in Journal of endocrinological investigation (09-11-2024)Get full text
Journal Article -
14
Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how
Published in Journal of endocrinological investigation (03-10-2024)“…Skeletal comorbidities are frequent and clinically relevant findings in Cushing's syndrome (CS) since an uncoupled suppressed bone formation and enhanced bone…”
Get full text
Journal Article -
15
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma
Published in The journal of clinical endocrinology and metabolism (01-04-2017)“…In 2007, a retrospective case-control study provided evidence that adjuvant mitotane prolongs recurrence-free survival (RFS) in patients with radically…”
Get full text
Journal Article -
16
Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease
Published in Baillière's best practice & research. Clinical endocrinology & metabolism (01-03-2021)“…Pathophysiology and effects of endogenous glucocorticoid (GC) excess on skeletal endpoints as well as awareness and management of bone fragility are reviewed…”
Get full text
Journal Article -
17
Novel approaches to bone comorbidity in Cushing’s disease: an update
Published in Pituitary (01-10-2022)“…Skeletal complications are frequent and clinically relevant findings in Cushing’s disease (CD) since an uncoupled suppressed bone formation and enhanced bone…”
Get full text
Journal Article -
18
Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
Published in The journal of clinical endocrinology and metabolism (01-03-2015)“…Background: Recurrence of adrenocortical carcinoma (ACC) even after complete (R0) resection occurs frequently. Objective: The aim of this study was to identify…”
Get full text
Journal Article -
19
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study
Published in The journal of clinical endocrinology and metabolism (18-09-2023)“…Abstract Context Because of the rarity of adrenocortical cancer (ACC), only a few population-based studies are available, and they reported limited details in…”
Get full text
Journal Article -
20
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Published in The New England journal of medicine (07-06-2007)“…This retrospective analysis assessed the efficacy of adjuvant mitotane treatment in prolonging recurrence-free survival in adrenocortical cancer, which carries…”
Get full text
Journal Article